(2) As used in this section, "automatic vending machine" means any mechanical device or contrivance whereby the purchaser is able to secure drugs.
(3) A person may not adulterate for the purpose of sale any drug in such manner as to render it injurious to health, or knowingly sell or offer for sale any adulterated drug.
(4) A person may not manufacture, compound or sell or offer for sale or cause to be manufactured, compounded, sold or offered for sale any drug, compound or preparation for internal or external use under or by a name recognized in the United States Pharmacopoeia, Homeopathic Pharmacopoeia or National Formulary which differs from the standard of strength and purity specified therein as official at the time of manufacture, compounding, sale or offering for sale.
(5) A person may not manufacture, compound, sell or offer for sale, or cause to be manufactured, sold or offered for sale, any drug, the strength and purity of which falls below the professed standard of strength and purity under which it is sold.
(6) A person may not sell, give away, barter, dispense, distribute, buy, receive or possess any prescription drug except as authorized by law.
(7) A manufacturer or wholesaler may not sell or otherwise distribute, or offer to sell or otherwise distribute, any drug or device except to a person legally authorized to resell, dispense or otherwise redistribute such drug or device. The board may grant an exemption from the requirement of this subsection in the form of a special permit if the board finds that an exemption is in the best interest of the public health and safety.
(8)(a) A person may not sell, purchase or trade or offer to sell, purchase or trade any drug sample.
(b) As used in paragraph (a) of this subsection, "drug sample" means a unit of a drug, subject to this chapter, that is not intended to be sold and is intended to promote the sale of the drug, and includes a coupon or other form which may be redeemed for a drug.
(9) For purposes of this section and ORS 678.375, distribution of prepackaged complimentary samples of medications by a nurse practitioner or clinical nurse specialist with prescription writing authority shall not constitute dispensing when the sample medication is within the prescriptive authority granted to that nurse practitioner or clinical nurse specialist. [Formerly 689.765]
Structure 2021 Oregon Revised Statutes
Chapter 689 - Pharmacists; Drug Outlets; Drug Sales
Section 689.005 - Definitions.
Section 689.025 - Policy; purpose.
Section 689.045 - Severability.
Section 689.115 - Membership; qualifications; term; vacancy; compensation.
Section 689.135 - General powers of board; fees.
Section 689.151 - Board control over licensing, standards and discipline.
Section 689.155 - Authority of board over medications, drugs, devices and other materials; rules.
Section 689.165 - Officers; executive director.
Section 689.175 - Compensation of board members and executive director.
Section 689.207 - Authority of board to require fingerprints.
Section 689.255 - Qualifications for licensure by examination.
Section 689.265 - Qualifications for licensure by reciprocity.
Section 689.275 - Renewal of licenses; rules; fees.
Section 689.285 - Continuing education; rules; fees.
Section 689.305 - Registration of drug outlets; rules.
Section 689.315 - Application; rules.
Section 689.325 - Required reports.
Section 689.335 - Certificate required; reinstatement.
Section 689.405 - Grounds for discipline; investigation; procedure as contested case.
Section 689.445 - Penalties and reinstatement.
Section 689.490 - Board to establish licensing system; rules; fees.
Section 689.495 - Provision of licensing information.
Section 689.497 - Report required upon termination of pharmacy technician.
Section 689.499 - Pharmacy technician specialized education program; rules.
Section 689.503 - Licensing of pharmaceutical representatives; civil penalty; rules.
Section 689.505 - Labeling requirements; rules.
Section 689.515 - Regulation of generic drugs; substitutions; rules.
Section 689.522 - Substitution of biological products for prescribed biological products; rules.
Section 689.524 - Approval of coverage for biological product.
Section 689.525 - Out-of-state prescriptions.
Section 689.527 - Prohibited practices; rules.
Section 689.555 - Agricultural drugs and certain other substances.
Section 689.561 - Prescription readers; compatible labels; exception; rules.
Section 689.615 - Display of certificate or license; rules.
Section 689.645 - Vaccines, patient care services, drugs and devices; formulary; rules.
Section 689.649 - Public Health and Pharmacy Formulary Advisory Committee.
Section 689.655 - Power to administer drugs and devices; rules.
Section 689.661 - Power to perform tests and examinations related to federally cleared analytes.
Section 689.681 - Opiate overdose; treatments; administration of naloxone; rules.
Section 689.682 - Prescription of naloxone.
Section 689.684 - Administration of naloxone by certain persons; rules.
Section 689.686 - Notice of availability of naloxone; rules.
Section 689.692 - Dispensation of prescription drug containing cannabinoids; rules.
Section 689.700 - Telepharmacy; requirements; rules.
Section 689.704 - Preexposure and post-exposure antiretroviral therapies; HIV tests; rules.
Section 689.770 - Definitions for ORS 689.770 to 689.780.
Section 689.772 - Establishment of program; immunity from liability; rules; fee.
Section 689.776 - Inspection; audit.
Section 689.778 - Eligibility.
Section 689.832 - Civil penalties.
Section 689.854 - Civil penalty for violation of ORS 689.515.